Notice of Results
22/03/2023 07:00
For best results when printing this announcement, please click on link below: http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230322:nRSV7810Ta&default-theme=true RNS Number : 7810T Medica Group PLC 22 March 2023 22 March 2023 Medica Group Plc Notice of Results Medica Group Plc (LSE: MGP, "Medica", the "Company" or the "Group"), an international provider of high-quality telemedicine services, intends to announce its preliminary results for the year ended 31 December 2022 on Wednesday 29 March 2023. A presentation for analysts will be held at 9.00am on that day at the offices of FTI Consulting at 200 Aldersgate Street, London, EC1A 4HD. For further information, please contact: Medica Group Plc: +44 (0)33 33 111 222 Stuart Quin, Chief Executive Officer Richard Jones, Chief Financial Officer FTI Consulting +44 (0)20 3727 1000 Victoria Foster Mitchell Sam Purewal Liberum (Joint Broker) +44 (0)20 3100 2000 Phil Walker Richard Lindley Numis (Joint Broker) +44 (0)20 7260 1000 Freddie Barnfield Duncan Monteith Euan Brown About Medica Group PLC Medica (LSE:MGP) is an international provider of high-quality telemedicine services. It is the market leader in teleradiology in the UK and Ireland, working with more than 100 NHS Trusts and HSE hospitals in Ireland, in addition to private hospitals, insurance groups and diagnostic imaging companies. Its network of consultant radiologists, radiographers and specialist doctors interpret and report MRI, CT, ultrasound and X-ray images on behalf of healthcare providers, using Medica's bespoke, secure technology platform for fast and responsive delivery. The Company's core services include NightHawk, an urgent, out-of-hours offering available to clients 24/7 with dedicated pathways for stroke and major trauma, and Elective, for routine reporting. In Ireland, Medica carries out patient scanning, as well as reporting, and runs a diabetic retinopathy screening programme for the National Screening Service. Through its US business, RadMD, Medica provides global pharmaceutical and biotech companies, as well as contract research organisations with specialist imaging services for clinical trials. For more information, please visit: www.medicagroupplc.com (http://www.medicagroupplc.com/) This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com (mailto:rns@lseg.com) or visit www.rns.com (http://www.rns.com/) . RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy) . END NORSEAEFFEDSEFD